Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Educational Curricula and Programs in Adolescent Medicine for Health Workers in Low- and Middle-Income Countries: A Scoping Review.

Miller KK, Brown SJ, Pfeffer B, Olupot-Olupot P, Kitaka S.

J Grad Med Educ. 2019 Aug;11(4 Suppl):64-72. doi: 10.4300/JGME-D-19-00052. Review.

PMID:
31428260
2.

Xpert MTB/RIF Ultra for Tuberculosis Testing in Children: A Mini-Review and Commentary.

Atherton RR, Cresswell FV, Ellis J, Kitaka SB, Boulware DR.

Front Pediatr. 2019 Feb 28;7:34. doi: 10.3389/fped.2019.00034. eCollection 2019. Review.

3.

Prevalence and associated factors of attention deficit hyperactivity disorder (ADHD) among Ugandan children; a cross-sectional study.

Wamulugwa J, Kakooza A, Kitaka SB, Nalugya J, Kaddumukasa M, Moore S, Sajatovic M, Katabira E.

Child Adolesc Psychiatry Ment Health. 2017 Apr 14;11:18. doi: 10.1186/s13034-017-0155-6. eCollection 2017.

4.

Pharmacokinetics of zidovudine dosed twice daily according to World Health Organization weight bands in Ugandan HIV-infected children.

Fillekes Q, Kendall L, Kitaka S, Mugyenyi P, Musoke P, Ndigendawani M, Bwakura-Dangarembizi M, Gibb DM, Burger D, Walker AS; ARROW Trial Team.

Pediatr Infect Dis J. 2014 May;33(5):495-8. doi: 10.1097/INF.0000000000000143.

5.

Incidence and risk factors for first line anti retroviral treatment failure among Ugandan children attending an urban HIV clinic.

Sebunya R, Musiime V, Kitaka SB, Ndeezi G.

AIDS Res Ther. 2013 Nov 11;10(1):25. doi: 10.1186/1742-6405-10-25.

6.

Prospective long-term outcomes of a cohort of Ugandan children with laboratory monitoring during antiretroviral therapy.

Kekitiinwa A, Asiimwe AR, Kasirye P, Korutaro V, Kitaka S, Maganda A, Madalon M, Graziano FM.

Pediatr Infect Dis J. 2012 Aug;31(8):e117-25. doi: 10.1097/INF.0b013e31825cb9d6.

PMID:
22581223
7.

The African Vaccine-Preventable Diseases Network: a vaccine advocacy initiative.

Wiysonge CS, Armah GE, Madhi SA, Were F, Kitaka SB, Akoua-Koffi C, Gresenguet G, Gatheru Z, Maranga PW, Dicko A, Falade AG, Boula AY, Kuit SB, Odusanya OO, Sow PS, Lakhani N, Mpabalwani EM, Tamfum JJ, Hussey GD.

Pan Afr Med J. 2011;8:24. Epub 2011 Mar 14.

8.

Development and initial validation of the thyroid cancer module of the M. D. Anderson Symptom Inventory.

Gning I, Trask PC, Mendoza TR, Harle MT, Gutierrez KA, Kitaka SA, Sherman SI, Cleeland CS.

Oncology. 2009;76(1):59-68. doi: 10.1159/000178809. Epub 2008 Dec 1.

PMID:
19052478
9.

Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland.

Kekitiinwa A, Lee KJ, Walker AS, Maganda A, Doerholt K, Kitaka SB, Asiimwe A, Judd A, Musoke P, Gibb DM; Collaborative HIV Paediatric Study (CHIPS) Steering Committe; Mulago Cohort Team.

J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):384-92. doi: 10.1097/QAI.0b013e31818cdef5.

PMID:
18931630
10.

Monoclonal antibodies against Enterocytozoon bieneusi of human origin.

Sheoran AS, Feng X, Singh I, Chapman-Bonofiglio S, Kitaka S, Hanawalt J, Nunnari J, Mansfield K, Tumwine JK, Tzipori S.

Clin Diagn Lab Immunol. 2005 Sep;12(9):1109-13.

11.

Purification of Enterocytozoon bieneusi from stools and production of specific antibodies.

Sheoran AS, Feng X, Kitaka S, Green L, Pearson C, Didier ES, Chapman S, Tumwine JK, Tzipori S.

J Clin Microbiol. 2005 Jan;43(1):387-92.

Supplemental Content

Loading ...
Support Center